BMI1 promotes steroidogenesis through maintaining redox homeostasis in mouse MLTC-1 and primary Leydig cells

Tingting Gao,Meng Lin,Binbin Shao,Qiao Zhou,Yufeng Wang,Xia Chen,Dan Zhao,Xiuliang Dai,Cong Shen,Hongbo Cheng,Shenmin Yang,Hong Li,Bo Zheng,Xingming Zhong,Jun Yu,Li Chen,Xiaoyan Huang
DOI: https://doi.org/10.1080/15384101.2020.1779471
Cell Cycle
Abstract:In males, aging is accompanied by decline in serum testosterone levels due to impairment of testicular Leydig cells. The polycomb protein BMI1 has recently been identified as an anti-aging factor. In our previous study, BMI1 null mice showed decreased serum testosterone and Leydig cell population, excessive oxidative stress and p16/p19 signaling activation. However, a cause-and-effect relationship between phenotypes and pathways was not investigated. Here, we used the rescue approach to study the role of oxidative stress or p16/p19 in BMI1-mediated steroidogenesis. Our results revealed that treatment with antioxidant NAC, but not down-regulation of p16/p19, largely rescued cell senescence, DNA damage and steroidogenesis in BMI1-deficient mouse MLTC-1 and primary Leydig cells. Collectively, our study demonstrates that BMI1 orchestrates steroidogenesis mainly through maintaining redox homeostasis, and thus, BMI1 may be a novel and potential therapeutic target for treatment of hypogonadism.
What problem does this paper attempt to address?